Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription - Top-Institutions - MDSpire

Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription

By
Mitsuru Okubo
Tomohiro Itonaga
Tatsuhiko Zama
Ryuji Mikami
Yukinori Okada
Tsubasa Kawamoto
Shiho Wada
Shinji Sugahara
Kazuhiro Saito
May 18, 2026
0 min

Frontiers In Medicine

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

The University of Texas MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Radiation Oncology
#2

Memorial Sloan-Kettering Cancer Center

New York, New York
Key Differentiators
- Radiation Oncology
#3

Radiation Therapy Oncology Group (RTOG)

Philadelphia, Pennsylvania
Key Differentiators
- Radiation Oncology
#4

Levine Cancer Institute

Charlotte, North Carolina
Key Differentiators
- Radiation Oncology
#5

Stanford University

Stanford, California
Key Differentiators
- Radiation Oncology

Original Source(s)

Frontiers In Medicine

Dosimetric and clinical outcomes of stereotactic body radiotherapy for primary lung cancer: isocenter-based vs. volume-based prescription

by Mitsuru Okubo, Tomohiro Itonaga, Tatsuhiko Zama, Ryuji Mikami, Yukinori Okada, Tsubasa Kawamoto, Shiho Wada, Shinji Sugahara, Kazuhiro Saito
May 18, 2026

Related Content

Stat News

An ASCO preview: What to watch for at cancer research’s big meeting

by Adam Feuerstein
May 28, 2026

Frontiers In Oncology

Solid-variant primary pulmonary adenoid cystic carcinoma with pleural metastasis and malignant pleural effusion: a rare case report

by Suyi Guo, Yang Zhai, Hongbian Gao, Caixia Ding
May 18, 2026

Frontiers In Immunology

Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP